The Global Castrate-Resistant Prostate Cancer Treatment Market size was valued at USD 8.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8% from 2022 to 2028. Castration-resistant prostate cancer (CRPC) or hormone refractory prostate cancer (CRPC) is a type of prostate cancer that recurs after administration of […]
